Gastroenterology
Volume 135, Issue 1 , Pages 111-121 , July 2008

Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan

  • Chi–Ling Chen

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine, College of Public Health, National Taiwan University, Taipei
    • ,
  • Hwai–I. Yang

      Affiliations

    • Genomics Research Center, Academia Sinica, Taipei
    • ,
  • Wei–Shiung Yang

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine, College of Public Health, National Taiwan University, Taipei
    • Department of Internal Medicine, National Taiwan University Hospital, Taipei
    • ,
  • Chun–Jen Liu

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine, College of Public Health, National Taiwan University, Taipei
    • Department of Internal Medicine, National Taiwan University Hospital, Taipei
    • Hepatitis Research Center, National Taiwan University Hospital, Taipei
    • ,
  • Pei–Jer Chen

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine, College of Public Health, National Taiwan University, Taipei
    • Department of Internal Medicine, National Taiwan University Hospital, Taipei
    • Hepatitis Research Center, National Taiwan University Hospital, Taipei
    • ,
  • San–Lin You

      Affiliations

    • Genomics Research Center, Academia Sinica, Taipei
    • ,
  • Li–Yu Wang

      Affiliations

    • Department of Public Health, Tzu-Chi University, Hualien
    • ,
  • Chien–An Sun

      Affiliations

    • School of Public Health, National Defense Medical Center, Taipei
    • ,
  • Sheng–Nan Lu

      Affiliations

    • Department of Gastroenterology, Kaohsiung Chang-Gung Memorial Hospital, Kaohsiung, Taiwan
    • ,
  • Ding–Shin Chen

      Affiliations

    • Graduate Institute of Clinical Medicine, College of Medicine, College of Public Health, National Taiwan University, Taipei
    • Department of Internal Medicine, National Taiwan University Hospital, Taipei
    • Hepatitis Research Center, National Taiwan University Hospital, Taipei
    • ,
  • Chien–Jen Chen

      Affiliations

    • Genomics Research Center, Academia Sinica, Taipei
    • Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei
    • Corresponding Author InformationAddress requests for reprints to: Chien-Jen Chen, ScD, Genomics Research Center, Academia Sinica, 128 Academia Road, Section 2, Nankang, Taipei 115, Taiwan.

Received 11 January 2008 ,Accepted 27 March 2008.

References 

  1. Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5–S16
  2. Moller H, Mellemgaard A, Lindvig K, et al. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer. 1994;30A:344–350
  3. Wolk A, Gridley G, Svensson M, et al. A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control. 2001;12:13–21
  4. Rapp K, Schroeder J, Klenk J, et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer. 2005;93:1062–1067
  5. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity and mortality from cancer in a prospective studied cohort of US adults. N Engl J Med. 2003;348:1625–1638
  6. Samanic C, Gridley G, Chow WH, et al. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control. 2004;15:35–43
  7. Nair S, Mason A, Eason J, et al. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?. Hepatology. 2002;36:150–155
  8. Lai MS, Hsieh MS, Chiu YH, et al. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology. 2006;43:1295–1302
  9. Adami HO, Chow WH, Nyrn O, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst. 1996;88:1472–1477
  10. Wideroff L, Gridley G, Mellemkjaer L, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 1997;89:1360–1365
  11. La Vecchia C, Negri E, Decarli A, et al. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer. 1997;73:204–207
  12. Lagiou P, Kuper H, Stuver SO, et al. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst. 2000;92:1096–1099
  13. El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans. Am J Gastroenterol. 2001;96:2462–2467
  14. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gasteroenterology. 2004;126:460–468
  15. Davila JA, Morgan RO, Shaib Y, et al. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 2005;54:533–539
  16. Hassan MM, Hwang LY, Hatten CJ, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology. 2002;36:1206–1213
  17. Jee SH, Ohrr H, Sull JW, et al. Fasting serum glucose level and cancer risk in Korea men and women. JAMA. 2005;293:194–202
  18. Coughlin SS, Calle EE, Teras LR, et al. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol. 2004;159:1160–1167
  19. Yuan JM, Govindarajan S, Arakawa K, et al. Synergism of alcohol, diabetes, and viral hepatitis on risk of hepatocellular carcinoma in blacks and whites in the U.S.. Cancer. 2004;101:1009–1017
  20. Inoue M, Iwasaki M, Otani T, et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med. 2006;166:1871–1877
  21. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systemic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006;4:369–430
  22. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65–73
  23. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002;347:168–174
  24. Iloeje U, Yang HI, Su J, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006;130:678–686
  25. Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care. 2004;27(5):1182–1186
  26. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:1077
  27. Walker AM. Proportion of disease attributable to the combined effect of two factors. Int J Epidemiol. 1981;10:81–85
  28. Stata version 8.0. College Station, TX: Stata Corp.
  29. Motta M, Giugno I, Ruello P, et al. Lipoprotein (a) behaviour in patients with hepatocellular carcinoma. Minerva Med. 2001;92:301–305
  30. Jan CF, Chen CJ, Chiu YH, et al. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based integrated screening study No. 10). Int J Obes. 2006;1–6
  31. Kang SK, Chung TW, Lee JY, et al. The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III. J Biol Chem. 2004;279:28106–28112
  32. Melegari M, Wolf SK, Schneider RJ. Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression. J Virol. 2005;79:9810–9820
  33. Yu MC, Yuan JM. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology. 2004;127:S72–S78
  34. Zen Y, Katayanagi K, Tsuneyama K, et al. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. Pathol Int. 2001;51:127–131
  35. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of non-alcoholic steatohepatitis from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology. 2002;123:134–140
  36. Adinolfi LE, Gambardella M, Andreana A, et al. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology. 2001;33:1358–1364
  37. Ohata K, Hamasaki K, Torihama K, et al. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer. 2003;97:3036–3043
  38. Okura Y, Urban LH, Mahoney DW, et al. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol. 2004;57:1096–1103
  39. Chang MH, Shau WY, Chen CJ, et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA. 2000;284:3040–3042
  40. Chien YC, Jan CF, Kuo HS, et al. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev. 2006;28:126–135
  41. El-Serag HB, Mason HC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;19:221–229
  42. El-Serag HB, Davila JA, Peteren NJ, et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817–823
  43. Dixon JB, Bhathal PS, O'Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histological improvement. Obes Surg. 2006;16:1278–1286

 Supported by grant NSC-94-2314-B002-268 from the National Science Council and Department of Health, Executive Yuan, Taiwan.

 The authors report that no conflicts of interest exist.

PII: S0016-5085(08)00569-6

doi: 10.1053/j.gastro.2008.03.073

Gastroenterology
Volume 135, Issue 1 , Pages 111-121 , July 2008

Article Tools